Spontaneous ascending aortic intramural haematoma in a patient on dabigatran

Interactive Cardiovascular and Thoracic Surgery

Volumn 15, Issue 2, 2012, Pages 299-300

  Mastrobuoni, Stefano ^a   Robblee, James A ^a   Boodhwani, Munir ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

dabigatran; Intramural haematoma

Indexed keywords

BLOOD CLOTTING FACTOR 7; D DIMER; DABIGATRAN; PROTHROMBIN COMPLEX; WARFARIN;

AGED; AORTA ATHEROSCLEROSIS; ARTICLE; ASCENDING AORTA; BACKACHE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRYOPRECIPITATE; DRUG SAFETY; DYSPNEA; FEMALE; HEMATOMA; HUMAN; MEDIASTINUM DISEASE; PARTIAL THROMBOPLASTIN TIME; PERICARDIAL EFFUSION; PRIORITY JOURNAL; THORACIC AORTA SURGERY; THORAX PAIN; THORAX RADIOGRAPHY; THROMBIN TIME; VALVED CONDUIT;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; AORTIC DISEASES; AORTIC VALVE; BENZIMIDAZOLES; BETA-ALANINE; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHEST PAIN; DYSPNEA; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HEMATOMA; HUMANS; PERICARDIAL EFFUSION; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84869420395     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs220     Document Type: Article

References (10)

1. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr et al. 2010 ACCF/AHA/AATA/ACR/ ASA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol 2010;55:e27-129
2. Moore C, Snashall J, Boniface K, Scott J. Spontaneous splenic hemorrhage after initiation of dabigatran (Pradaxa) for atrial fibrillation. Am J Emerg Med 2011 [Epub ahead of print].
3. Connoly S, Ezekowitz M, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51
4. van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M et al. Dabigatran etexilate - a novel reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010;103:116-27
5. Wann LS, Curtis AB, Ellenbogen KA, Estes NA III, Ezekowitz MD, Jackman WM et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report f the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2011;57:1330-7.
6. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr et al. 2010 ACCF/AHA/AATA/ACR/ ASA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol 2010;55:e27-129
7. Moore C, Snashall J, Boniface K, Scott J. Spontaneous splenic hemorrhage after initiation of dabigatran (Pradaxa) for atrial fibrillation. Am J Emerg Med 2011 [Epub ahead of print].
8. Connoly S, Ezekowitz M, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51
9. van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M et al. Dabigatran etexilate - a novel reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010;103:116-27
10. Wann LS, Curtis AB, Ellenbogen KA, Estes NA III, Ezekowitz MD, Jackman WM et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report f the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2011;57:1330-7.